Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Mesa Laboratories Inc before investing.

In this article, we go over a few key elements for understanding Mesa Laboratories Inc’s stock price such as:

• Mesa Laboratories Inc’s current stock price and volume
• Why Mesa Laboratories Inc’s stock price changed recently
• Upgrades and downgrades for MLAB from analysts
• MLAB’s stock price momentum as measured by its relative strength

About Mesa Laboratories Inc (MLAB)

Before we jump into Mesa Laboratories Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Mesa Laboratories, Inc. is a multinational manufacturer, developer, and seller of life sciences tools and critical quality control solutions. Its segments include Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. Its Clinical Genomics segment develops, manufactures, and sells throughput genetic analysis tools used by labs to perform clinical genomic testing in several therapeutic areas. Its Sterilization and Disinfection Control segment manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization and disinfection processes. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Calibration Solutions segment develops, manufactures, and sells quality control products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters.

Want to learn more about Mesa Laboratories Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Mesa Laboratories Inc.

Mesa Laboratories Inc’s Stock Price as of Market Close

As of April 23, 2024, 4:00 PM, CST, Mesa Laboratories Inc’s stock price was $106.62.

Mesa Laboratories Inc is up 4.26% from its previous closing price of $102.26.

During the last market session, Mesa Laboratories Inc’s stock traded between $99.54 and $103.55. Currently, there are 5.39 million shares of Mesa Laboratories Inc stock available for purchase.

Mesa Laboratories Inc’s price-earnings (P/E) ratio is currently at 583.9, which is high compared to the Medical Equipment, Supplies & Distribution industry median of 36.3. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Mesa Laboratories Inc Stock Price History

Mesa Laboratories Inc’s (MLAB) price is currently down 2.83% so far this month.

During the month of April, Mesa Laboratories Inc’s stock price has reached a high of $112.55 and a low of $97.75.

Over the last year, Mesa Laboratories Inc has hit prices as high as $178.64 and as low as $82.86. Year to date, Mesa Laboratories Inc’s stock is down 35.85%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Mesa Laboratories Inc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of April 22, 2024,, no analysts have changed their rating of Mesa Laboratories Inc’s stock over the last month.

Additionally, you'll want to evaluate Mesa Laboratories Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Mesa Laboratories Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Mesa Laboratories Inc’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Mesa Laboratories Inc (MLAB) by visiting AAII Stock Evaluator.

Relative Price Strength of Mesa Laboratories Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 22, 2024, Mesa Laboratories Inc has a weighted four-quarter relative price strength of -10.84%, which translates to a Momentum Score of 30 and is considered to be Weak.

Want to learn more about how Mesa Laboratories Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Mesa Laboratories Inc Stock Price: Bottom Line

As of April 23, 2024, Mesa Laboratories Inc’s stock price is $106.62, which is up 4.26% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Mesa Laboratories Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.